| Gene symbol | IGK | Synonyms | IGK@ | Type of gene | protein-coding |
| Chromosome | 2 | Map location | 2p11.2 | dbXrefs | |
| Description | immunoglobulin kappa locus | ||||
| GTO ID | GTC2284 |
| Trial ID | NCT04223765 |
| Disease | Splenic Marginal Zone Lymphoma | Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Nodal Marginal Zone Lymphoma | Follicular Lymphoma |
| Altered gene | IGK |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | Kappa CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. |
| Year | 2020 |
| Country | United States |
| Company sponsor | UNC Lineberger Comprehensive Cancer Center |
| Other ID(s) | LCCC 1811-ATL |
| Cohort 1 | |||||||||||||
|
|||||||||||||